Brief: CytoTools AG: presents a revised strategy for the marketing of DermaPro

bioXXmed AG

31/01/2017 10:28

Jan 31 (Reuters) - CytoTools AG  T5OG.DE : 
    * New chief medical officer Wilfried Hauke presents a 
revised strategy for the marketing of DermaPro 
    * Still strives for DermaPro to be approved as a drug with a 
modification of the previous development strategy, which 
basically aims at a repeat of the clinical phase III 
 
Source text for Eikon:  ID:nEQ3LByty  
Further company coverage:  T5OG.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))